SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-1 - Registration statement for certain foreign private issuers:
SEC Accession No. 0001564590-20-040079
Filing Date
2020-08-13
Accepted
2020-08-13 17:25:15
Documents
18

Document Format Files

Seq Description Document Type Size
1 FORM F-1 lmnl-f1_20200521.htm F-1 1850213
2 EX-5.1 lmnl-ex51_227.htm EX-5 37410
3 EX-23.1 lmnl-ex231_228.htm EX-23 4310
4 EX-23.2 lmnl-ex232_226.htm EX-23 3361
5 GRAPHIC gclegcihmgmp000001.jpg GRAPHIC 4527
6 GRAPHIC gclegcihmgmp000002.jpg GRAPHIC 15932
7 GRAPHIC gclegcihmgmp000003.jpg GRAPHIC 15701
8 GRAPHIC gclegcihmgmp000004.jpg GRAPHIC 11169
9 GRAPHIC gclegcihmgmp000005.jpg GRAPHIC 23512
10 GRAPHIC gclegcihmgmp000006.jpg GRAPHIC 41653
11 GRAPHIC gclegcihmgmp000007.jpg GRAPHIC 8065
12 GRAPHIC gclegcihmgmp000008.jpg GRAPHIC 118798
13 GRAPHIC gclegcihmgmp000009.jpg GRAPHIC 23560
14 GRAPHIC gclegcihmgmp000010.jpg GRAPHIC 7909
15 GRAPHIC gclegcihmgmp000011.jpg GRAPHIC 4527
16 GRAPHIC gnf2z24vcb5s000001.jpg GRAPHIC 2990
17 GRAPHIC gnf2z24vcb5s000002.jpg GRAPHIC 31654
18 GRAPHIC gth03nav5w0o000001.jpg GRAPHIC 3495
  Complete submission text file 0001564590-20-040079.txt   2330228
Mailing Address 440 BOULEVARD ARMAND FRAPPIER #300 LAVAL A8 H7V 4B4
Business Address 440 BOULEVARD ARMAND FRAPPIER #300 LAVAL A8 H7V 4B4 514-341-2115
Liminal BioSciences Inc. (Filer) CIK: 0001351172 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1231
Type: F-1 | Act: 33 | File No.: 333-245703 | Film No.: 201100352
SIC: 2834 Pharmaceutical Preparations